Preparation, characterization and in vitro anticancer activity of platinum(2) complexes with N-cyclohexyl-1,3-propanediamine as the carrier

  • Liu Weiping
    Platinum-Based Drug Lab, Kunming Institute of Precious Metals
  • Qing Chen
    Kunming Medical College
  • Chen Xizhu
    Platinum-Based Drug Lab, Kunming Institute of Precious Metals
  • Ye Qingsong
    Platinum-Based Drug Lab, Kunming Institute of Precious Metals
  • Yu Yao
    Platinum-Based Drug Lab, Kunming Institute of Precious Metals
  • Hou Shuqian
    Platinum-Based Drug Lab, Kunming Institute of Precious Metals

書誌事項

タイトル別名
  • Preparation, Characterization and in Vitro Anticancer Activity of Platinum(II) Complexes with N-Cyclohexyl-1,3-propanediamine as the Carrier

この論文をさがす

抄録

New JM118 (active form of satraplatin) analogues with N-cyclohexyl-1,3-propanediamine (N-chpda) as the carrier, cis-[Pt(N-chpda)X2] (X2=2Cl (1), oxalate (2), malonate (3), 1,1-cyclobutanedicarboxylate (CBDCA) (3), and 3-hydroxy-1,1-cyclobutanedicarboxylate(HO-CBDCA) (4)), have been synthesized and characterized by elemental analysis and spectroscopic data along with X-ray crystal structure for a representative compound cis-[Pt(N-chpda)Cl2].The complexes have also been evaluated for their in vitro anticancer activity. All these analytical data are in good agreement with the structures of the desired compounds. The Pt(II) is in a square planar environment and is coordinated by a chelating N-chpda ligand and 2Cl in cis position, and there are two crystallographically independent cis-[Pt(N-chpda)Cl2] molecules linked together by intermolecular N–H···Cl hydrogen bonds. Compounds 1 and 2 are very active against human lung cancer cell line (AGZY) and human lymphocytic leukemia cell line (Raji), and are much more active than carboplatin. Platinum(II) complexes with N-cyclohexyl-1,3-propanediamine is an alternative choice for mixed ammine/aminoplatinum anticancer drugs.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (45)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ